France Advances Medical Cannabis Legalization with Key Regulatory Step
The Ministry of Health has notified the European Commission of regulatory texts, extending patient access during the transition and awaiting further evaluations.
- The French government has officially restarted the medical cannabis legalization process by notifying the European Commission of regulatory texts defining its framework.
- The experimental program benefiting 1,200 patients has been extended until March 31, 2026, ensuring continued access during the transition period.
- Medical cannabis will be prescribed only when other treatments fail, with initial prescriptions required to be issued in a hospital setting.
- The Ministry of Health has requested an evaluation from the Haute Autorité de Santé to assess the therapeutic benefits of medical cannabis and determine potential reimbursement policies.
- The regulatory framework includes a renewable five-year authorization period, reflecting a cautious approach to balancing patient needs, scientific evidence, and regulatory oversight.
Sud Ouest 
Le Nouvel Obs 